Advertisement
ResearchIn-Press PreviewNeuroscienceTherapeutics
Open Access | 10.1172/JCI165908
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by
Takahashi, K.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by Eultgen, E. in: JCI | PubMed | Google Scholar
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by Wang, S. in: JCI | PubMed | Google Scholar
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by Rensing, N. in: JCI | PubMed | Google Scholar
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by
Nelvagal, H.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by
Dearborn, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by Danos, O. in: JCI | PubMed | Google Scholar
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by
Buss, N.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by Sands, M. in: JCI | PubMed | Google Scholar
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by
Wong, M.
in:
JCI
|
PubMed
|
Google Scholar
|
1Department of Pediatrics, Washington University in St Louis School of Medicine, St. Louis, United States of America
2Department of Neurology, Washington University in St Louis School of Medicine, St. Louis, United States of America
3Department of Medicine, Washington University in St Louis School of Medicine, St. Louis, United States of America
4Research and Development, REGENXBIO, Inc., Rockville, United States of America
Find articles by
Cooper, J.
in:
JCI
|
PubMed
|
Google Scholar
|
Published April 27, 2023 - More info
Although a disease-modifying therapy for CLN2 disease now exists, a poor understanding of cellular pathophysiology has hampered the development of more effective and persistent therapies. Here, we investigated the nature and progression of neurological and underlying neuropathological changes in Cln2R207X mice, which carry one of the most common pathogenic mutations in human patients, but are yet to be fully characterized. Long-term electroencephalography recordings revealed progressive epileptiform abnormalities including spontaneous seizures, providing a robust and quantifiable disease-relevant phenotype. These seizures were accompanied by the loss of multiple cortical neuron populations, including those stained for interneuron markers. Further histological analysis revealed early localized microglial activation months before neuron loss started in the thalamocortical system and spinal cord, which was accompanied by astrogliosis. This pathology was more pronounced and occurred in the cortex before the thalamus or spinal cord, and differs markedly from the staging seen in mouse models of other forms of NCL. Neonatal administration of adeno-associated virus 9 (AAV9)-mediated gene therapy ameliorated the seizure and gait phenotypes and prolonged the lifespan of Cln2R207X mice, attenuating most pathological changes. Our findings highlight the importance of clinically relevant outcome measures for judging pre-clinical efficacy of therapeutic interventions for CLN2 disease.